Register
Login:
Share:
Email Facebook Twitter

EXCLUSIVE: Ascent CEO Colin Hutchinson with latest on review and permitting Watch Here

EXCLUSIVE: Ascent CEO Colin Hutchinson with latest on review and permitting


Akers Bio Share Price (AKR)



Share Price Information for Akers Bio (AKR)


Share Price: 21.50Bid: 18.00Ask: 25.00Change: 0.00 (0.00%)No Movement on Akers Bio
Spread: 7.00Spread as %: 38.89%Open: 21.50High: 21.50Low: 21.50Yesterday’s Close: 21.50

Akers Biosciences, Inc. Com Shs Npv

Akers Bio is listed in the FTSE AIM All-Share
Akers Bio is part of the Health Care and Related Services sector






Share Price SpacerPrice
21.50
Share Price SpacerBid
18.00
Share Price SpacerAsk
25.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
398
Share Price SpacerOpen
21.50
Share Price SpacerHigh
21.50
Share Price SpacerLow
21.50
Share Price SpacerClose
21.50
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 94.11m £20.23m 2,000

52 Week High 80.00 52 Week High Date 25-OCT-2017
52 Week Low 10.00 52 Week Low Date 10-AUG-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
2 0 199 -0.474 -45.39 0.00 0.00


London South East Users info for Akers Bio




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

16-Aug-18
11:35:23
18.00
199
Sell* 
18.00
25.00
35.82
Trade Type:
Ordinary

16-Aug-18
11:33:59
22.00
199
Buy* 
18.00
25.00
43.78
Trade Type:
Ordinary

14-Aug-18
15:41:27
19.00
108
Sell* 
18.00
25.00
20.52
Trade Type:
Ordinary




View more Akers Bio trades >>

Directors Deals for Akers Bio (AKR)
Trade DateActionNotifierPriceCurrencyAmountHolding
24-May-16Buy
Trade Notifier Information for Akers Biosciences, Inc.
John J. Gormally held the position of CEO at Akers Biosciences, Inc. at the time of this trade.
 John J. Gormally
2.19USD692500
24-May-16Buy
Trade Notifier Information for Akers Biosciences, Inc.
John J. Gormally held the position of CEO at Akers Biosciences, Inc. at the time of this trade.
 John J. Gormally
2.2USD1,0002500
24-May-16Buy
Trade Notifier Information for Akers Biosciences, Inc.
John J. Gormally held the position of CEO at Akers Biosciences, Inc. at the time of this trade.
 John J. Gormally
2.23USD1002500
View more Akers Bio directors dealings >>


bbr391
Posts: 5,370
Opinion:Strong Buy
Price:21.50
RE: Good news
Today 16:04
Bounced up despite bad earnings .
Weird share Indeed .

Best of All
bbr391
Posts: 5,370
Opinion:Strong Sell
Price:21.50
Good news
Wed 07:16
Over at other shares luckily ,will negate the continued disappointment here .

Best of All
bbr391
Posts: 5,370
Opinion:Strong Buy
Price:21.50
Warming
Tue 15:19
Upwards nicely .
This company may well be very undervalued as well as under pressure from shareholders .

Best of All
thomasbrowne
Posts: 254
Opinion:No Opinion
Price:21.50
Warning
Fri 17:36
Akers has took over $110million off investors for it shares and created 100s of millions of confetti shares and then it likes to consolidate them for 10 to 1 and then it looks for more money and starts creating 100s of millions of confetti shares again,,,,,,,,,, I'm one of the very few lucky investors who got out with a good profit at £2 ,,,,,, how lucky was I,,,,,,thank God it's old CEO is gone and after resigning,,,,,,you couldn't believe a word he utters,,,,,,,so be warned buy only if it's gambling money........and you believe you can trust its new CEO,,,,,,, the company is still in a mess,,,so be warned,,,and good luck ,,,,,,AIMHO,,,,,,
bbr391
Posts: 5,370
Opinion:Strong Buy
Price:21.50
Seems
Fri 16:26
Optimism from the US has transferred nicely.
Quite an unforgiving spread though.

Best of All
View more share chat for Akers Bio (AKR) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.